Publication | Closed Access
Familial Male Pseudohermaphroditism with Gynecomastia Due to a Testicular 17-Ketosteroid Reductase Defect. I. Studies<i>in Vivo</i>
177
Citations
0
References
1971
Year
SpermatogenesisMale DistributionFertilityNormal Breast DevelopmentPathologyGynecologyFemale Reproductive FunctionReproductive BiologyTesticular TumoursReproductive EndocrinologyNormal FemaleFemale InfertilityMale InfertilityReproductive MedicineGynecomastia DueWomen's PhysiologyPublic HealthDisorders Of Sex DevelopmentSteroid MetabolismReproductive HormoneInfertilityAndrologyI. StudiesEndocrinologyFamilial Male PseudohermaphroditismUrologyAdrenal HealthMenopauseMedicineEndocrine ResearchWomen's Health
A patient with familial male pseudohermaphroditism was considered to be a normal female up to the time of puberty. At puberty, she had normal breast development but there was simultaneous enlargement of the clitoris and the body hair developed with a male distribution. The internal genitalia were male in type. Under basal conditions, the plasma concentration of testosterone (T) was low for a male subject but plasma levels of dehydroepiandrosterone (DHA) and dehydroepiandrosterone sulfate (DHAS) were 2–3 times higher than those of normal men. The plasma level of androstenedione (Δ) was 10 times normal. Following gonadectomy, the pattern of plasma androgens was similar to that of a normal woman. Prior to operation, the basal urinary excretion of estrone, estradiol and estriol was much increased above that of a normal man but it became normal after gonadectomy. Eighteen months after gonadectomy, both before and after adrenal stimulation, the plasma androgens showed the pattern and concentrations expected in the normal adult female. The same could be said of the peripheral in terconversion between T & Δ. The data strongly suggest that the patient had an incomplete 17-ketosteroid reductase defect and that this defect was limited to the testes.